�ݺ�ߣ

List of Publications
PUBLICATIONS –RESEARCH *Corresponding Author
1. Rimpi and Rahul Deshmukh*., Embelin attenuates intracerebroventricular streptozotocin induced
behavioral, biochemical and neurochemical abnormalities in rats., Molecular Neurobiology
[Accepted] DOI: 10.1007/s12035-016-0182-y
2. Rahul Deshmukh*, Madhu Kaundal, Vikas Bansal, Samardeep. Caffeic acid attenuates oxidative
stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental
dementia in rats. Biomedicine & Pharmacotherapy 81 (2016) 56–62.
3. Manveen Bhardwaj, Rahul Deshmukh*, Madhu Kaundal, B V Krishna Reddy. Pharmacological
induction of hemeoxygenase-1 activity attenuates intracerebroventricular streptozotocin induced
neurocognitive deficit and oxidative stress in rats. Eur J Pharmacol 2016 Feb 19; 772:43-50.
4. Datta S, Jamwal S, Deshmukh R, Kumar P. Beneficial effects of lycopene against haloperidol
induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.
European journal of pharmacology. 2016; 771:229-35.
5. Sharma N1
, Bhandari S2
, Deshmukh R3
, Yadav AK4
, Mishra N1
. Development and characterization
of embelin-loaded nanolipid carriers for brain targeting. Artif Cells Nanomed Biotechnol. 2016 Mar
25:1-5. [Epub ahead of print]
6. Bhakuni GS, Bedi O, Bariwal J, Deshmukh R, Kumar P. Animal models of hepatotoxicity.
Inflammation Research. 2016;65 (1):13-24.
7. Kaur G, Bedi O, Sharma N, Singh S, Deshmukh R, Kumar P. Anti-hyperalgesic and anti-nociceptive
potentials of standardized grape seed proanthocyanidin extract against CCI-induced neuropathic pain
in rats. Journal of basic and clinical physiology and pharmacology. 2016;27(1):9-17.
8. Kaur N, JamwalS, Deshmukh R, Gauttam V, Kumar P. Beneficial effect of rice bran extract against
3-nitropropionic acid induced experimental Huntington's disease in rats. Toxicology Reports.
2015;2:1222-32.
9. Neha Soni, Prashant Koushal, B.V.K. Reddy, Rahul Deshmukh, Puneet Kumar. Effect of GLT-1
modulator and P2X7 antagonists alone and in combination in the Kindling model of epilepsy in rats.
Epilepsy Behav. 48: 4-14, 2015.
10. SK Kansal, U Jyoti, S Sharma, A Kaura, R Deshmukh, S Goyal; Effect of zinc supplements in the
attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart, Naunyn-
Schmiedeberg's Archives of Pharmacology, 1-7, 2015.
11. S Sharma, R Deshmukh*; Vinpocetine attenuates MPTP-induced motor deficit and biochemical
abnormalities in Wistar rats, Neuroscience 286, 393-403, 2015.

12. J Malik, K Munjal, R Deshmukh; Attenuating effect of standardized lyophilized Cinnamomum
zeylanicum bark extract against streptozotocin-induced experimental dementia of Alzheimer’s type;
Journal of basic and clinical physiology and pharmacology; 2014.
13. P Kumar, P Kumar, A Khan, R Deshmukh, PL Sharma; Role of neurosteroids in experimental 3-
nitropropionic acid induced neurotoxicity in rats, European journal of pharmacology 723, 38-45,
2014.
14. A Kumar, S Sharma, A Prashar, R Deshmukh*; Effect of licofelone—a dual COX/5-LOX inhibitor
in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats,
Journal of Molecular Neuroscience, 1-11, 2014.
15. Varun Vikas Vija, Gurmanpreet Kaura, Onkar Bedia, Vijay Kumara, Sumit Jamwalb, Puneet
Kumara, Rahul Deshmukh*, Combined effect of baclofen and acamprosate in experimental models
of peripheral neuropathic pain in Wistar rats. IPP, Vol 2 (4), 425-437, 2014.
16. RB Arora, K Kumar, RR Deshmukh*; FK506 attenuates intracerebroventricular streptozotocin-
induced neurotoxicity in rats, Behavioural Pharmacology 24 (7), 580-589; 2013.
17. T Thakur, S Sharma, K Kumar, R Deshmukh*,PL Sharma; Neuroprotective role of PDE4 and PDE5
inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats; European
journal of pharmacology 714 (1), 515-521; 2013.
18. J Malik, M Kumar, R Deshmukh, P Kumar; Ameliorating effect of lyophilized extract of Butea
frondosa leaves on scopolamine-induced amnesia in rats, Pharmaceutical biology 51 (2), 233-239,
2013
19. Rahul Deshmukh*, P L Sharma; Pharmacological inhibition of PDE1 by vinpocetine attenuates 3-
nitropropionic acid-induced behavioral and biochemical abnormalities in rats, IPP, Vol 1 (2), 145-
161, 2013.
20. RR Deshmukh*, PL Sharma; Stimulation of accumbens shell cannabinoid CB 1 receptors by noladin
ether, a putative endocannabinoid, modulates food intake and dietary selection in rats;
Pharmacological Research 66 (3), 276-282, 2012.
21. V Sharma, A Bala, R Deshmukh*, KL Bedi, PL Sharma; Neuroprotective effect of RO-20-1724-a
phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit
and oxidative stress in rats, Pharmacology Biochemistry and Behavior 101 (2), 239-245; 2012.
22. R Deshmukh*, PL Sharma; Activation of central cannabinoid CB1 receptors by WIN 55, 212-2
induces hyperphagia and facilitates preferential increase in palatable diet consumption in Wistar rats,
Int J Recent Adv Pharm Res 2, 62-69; 2012.

23. N Sharma, R Deshmukh*, KL Bedi; SP600125, a competitive inhibitor of JNK attenuates
streptozotocin induced neurocognitive deficit and oxidative stress in rats, Pharmacology Biochemistry
and Behavior 96 (4), 386-394, 2010.
24. R Deshmukh*, V Sharma, S Mehan, N Sharma, KL Bedi; Amelioration of intracerebroventricular
streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor,
European journal of pharmacology 620 (1), 49-56; 2009.
PUBLICATIONS –REVIEWS *Corresponding Author
1. Rani V, Deshmukh* R, Jaswal P, Kumar P, Bariwal J. Alzheimer's disease: Is this
a brain specific diabetic condition? Physiol Behav. 2016 Oct 1;164(Pt A):259-67.
2. Sahbaz Khan, Rahul Deshmukh*, Role of PDE inhibitors in rheumatoid arthritis and other
inflammatory diseases. PharmaAspire 2016, Vol:6, P, 28-36
3. Kumar A, Sharma V, Singh VP, Kaundal M, Gupta MK, Bariwal J, Deshmukh* R*
,
Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer's disease.
Mech. Ageing Dev. 2015 Jul; 149:75-87.
4. S Sharma, S Singh, V Sharma, VP Singh, R Deshmukh*; Neurobiology of l-DOPA induced
dyskinesia and the novel therapeutic strategies, Biomedicine & Pharmacotherapy 70, 283-293; 2015.
5. Sharma VK, Chandel A, Acharya G, Deshmukh* R. Endocannabinoid Systetm:
Neuropharmacological Implications. Med-Science. Online First: 20 Sep, 2015.
doi:10.5455/medscience.2015.04.8340
6. VK Sharma, P Sharma, R Deshmukh; R Singh, Age Associated Sleep Loss: A Trigger For
Alzheimer’s Disease, Bulletin of Clinical Psychopharmacology 25 (1), 78-88, 2015.
7. Varun Vikas Vij, Vishavdeep Sharma, Punit Kumar, Rahul Deshmukh*; Herbs as positive
modulator in neuropathic pain and their antinociceptive effect; , IPP, Vol 2 (3), 378-387, 2014.
8. K Kumar, S Sharma, P Kumar, R Deshmukh*; Therapeutic potential of GABAB receptor ligands in
drug addiction, anxiety, depression and other CNS disorders, Pharmacology Biochemistry and
Behavior 110, 174-184; 2013.
9. S Sharma, K Kumar, R Deshmukh*, PL Sharma; Phosphodiesterases: Regulators of cyclic
nucleotide signals and novel molecular target for movement disorders, European journal of
pharmacology 714 (1), 486-497; 2013.
10. A Mehta, M Prabhakar, P Kumar, R Deshmukh, PL Sharma; Excitotoxicity: bridge to various
triggers in neurodegenerative disorders, European journal of pharmacology 698 (1), 6-18, 2013.
11. V Sharma, P Sharma, R Deshmukh; Huntington's Disease: Clinical Complexities and Therapeutic
Strategies, Journal of Advanced Scientific Research 3 (2); 2012.

12. V Sharma, R Deshmukh; Tumor necrosis factor and Alzheimer’s disease: a cause and consequence
relationship, Bulletin of Clinical Psychopharmacology 22 (1), 86-97; 2012.
13. Sharma S, Deshmukh R, Sharma PL. Melanocortin System At the Crossroads of Obesity.
PharmaAspire 2010, Vol:2, P, 33-39

�ݺ�ߣ

List of Publications

More Related Content

List of Publications